Skip to main content
Log in

Synthesis and pharmacological evaluation of some new naphthol derived aryloxy derivatives as cognition enhancers

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

The present research was designed to describe the synthesis of a series of some 1-naphthol derivatives with their antiamnesic activity using mice as the animal model and piracetam as the reference drug. All the synthesized compounds were characterized by spectroscopic techniques, elemental analysis and were screened for their efficacy as cognition enhancers by elevated plus maze test and acetylcholinestrase inhibitory assay. Compound 7a was found to be the most potent in reversing the amnesia and in inhibiting the acetylcholinesterase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Scheme 2
Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Bartus RT, Dean RL, Pontecorvo MJ, Flicker C (1985) The cholinergic hypothesis: a historical overview, current perspective and future directions. Ann N Y Acad Sci 444:332–358

    Article  PubMed  CAS  Google Scholar 

  • Ellman GL, Courtney KD, Costa LG, Sether P, Enna SJ (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95

    Article  PubMed  CAS  Google Scholar 

  • Heise GA (1987) Facilitation of memory and cognition by drugs. Trends Pharmacol Sci 8:65–68

    Article  CAS  Google Scholar 

  • Hirai S (2000) Alzheimer disease: current therapy and future therapeutic strategies. Alzheimer Dis Assoc Disord 14(1):S11–S17

    Article  PubMed  CAS  Google Scholar 

  • Malik R, Sangwan A, Saigal R, Jindal DP, Piplani P (2007) Towards better brain management: nootropics. Curr Med Chem 14(2):123–131

    Article  PubMed  CAS  Google Scholar 

  • Marta M, Castellano C, Olivererino A, Pavone F, Pagella PG, Brufani M, Pompani M (1988) New analogs of physostigmine: alternative drugs for Alzheimer’s disease? Life Sci 43:1921–1928

    Article  PubMed  CAS  Google Scholar 

  • Parnetti L, Senin U, Mecoci P (1997) Cognitive enhancement therapy for Alzheimer’ disease: the way forward. Drugs 53(5):752–768

    Article  PubMed  CAS  Google Scholar 

  • Perry EK (1986) The cholinergic hypothesis—ten years on. Br Med Bull 42:63–69

    PubMed  CAS  Google Scholar 

  • Piplani P, Jindal DP, Gupta P, Malik R, Tiwari H, Kulkarni SK (2004) 2-Naphthyloxy derivatives of N,N-substituted acetamides: synthesis and pharmacological evaluation. Indian J Pharm Sci 66(5):653–658

    CAS  Google Scholar 

  • Refolo LM, Fillit HM (2004) Drug discovery for Alzheimer’s disease: the end of the beginning. J Mol Neurosci 24:1–8

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors are grateful to University Grants Commission, New Delhi, India for providing financial assistance to carry out this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Poonam Piplani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piplani, P., Malik, R., Kaur, B. et al. Synthesis and pharmacological evaluation of some new naphthol derived aryloxy derivatives as cognition enhancers. Med Chem Res 21, 1771–1779 (2012). https://doi.org/10.1007/s00044-011-9686-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-011-9686-1

Keywords

Navigation